EMvision Medical Financials
| EMV Stock | 1.89 0.04 2.07% |
Operating Margin (0.56) | Profit Margin (0.24) | Return On Equity (0.23) |
EMvision | Select Account or Indicator |
Understanding current and past EMvision Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of EMvision Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in EMvision Medical's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in EMvision Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of EMvision Medical Devices. Check EMvision Medical's Beneish M Score to see the likelihood of EMvision Medical's management manipulating its earnings.
EMvision Medical Stock Summary
EMvision Medical competes with AiMedia Technologies, Skycity Entertainment, Autosports, Australian Unity, and Hotel Property. EMvision Medical is entity of Australia. It is traded as Stock on AU exchange.| Foreign Associate | Switzerland |
Specialization | Health Care, Health Care Equipment & Services |
| Instrument | Australia Stock View All |
| Exchange | Australian Securities Exchange |
| ISIN | AU0000028375 |
| Business Address | 65 Epping Road, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.emvision.com.au |
| Phone | 61 2 8667 5337 |
You should never invest in EMvision Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of EMvision Stock, because this is throwing your money away. Analyzing the key information contained in EMvision Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
EMvision Medical Key Financial Ratios
EMvision Medical's financial ratios allow both analysts and investors to convert raw data from EMvision Medical's financial statements into concise, actionable information that can be used to evaluate the performance of EMvision Medical over time and compare it to other companies across industries.| Revenue | 11.22 M | ||||
| Gross Profit | 6.97 M | ||||
| EBITDA | (2.09 M) | ||||
| Net Income | (2.73 M) | ||||
| Total Asset | 23.97 M |
EMvision Medical Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 6.0M | 10.8M | 8.5M | 11.5M | 24.0M | 25.2M | |
| Other Current Liab | 170.1K | 313.1K | 478.9K | 682.7K | 2.1M | 2.2M | |
| Net Tangible Assets | 5.0M | 9.6M | 6.6M | 4.6M | 5.3M | 5.6M | |
| Net Debt | (5.4M) | (9.5M) | (6.1M) | (6.9M) | (15.7M) | (14.9M) | |
| Retained Earnings | (7.3M) | (15.7M) | (21.8M) | (25.7M) | (26.5M) | (25.2M) | |
| Accounts Payable | 319.6K | 193.7K | 178.2K | 330.7K | 293.5K | 221.1K | |
| Cash | 5.4M | 9.7M | 6.8M | 10.0M | 18.6M | 19.5M | |
| Net Receivables | 81.3K | 117.4K | 69.9K | 2.9M | 3.4M | 3.5M | |
| Inventory | (38.0K) | 51.1K | 130.1K | 5.9K | 6.8K | 6.5K | |
| Other Current Assets | 43.3K | 285.8K | 269.8K | 265.2K | 463.5K | 236.5K | |
| Total Liab | 489.7K | 720.0K | 1.4M | 6.4M | 5.5M | 5.7M | |
| Total Current Assets | 5.5M | 10.0M | 7.1M | 10.2M | 21.9M | 23.0M | |
| Common Stock | 12.0M | 21.4M | 23.2M | 26.2M | 41.6M | 21.1M | |
| Net Invested Capital | 5.5M | 10.1M | 7.1M | 7.6M | 21.1M | 22.2M | |
| Capital Stock | 12.0M | 21.4M | 23.2M | 26.2M | 41.6M | 24.2M | |
| Net Working Capital | 5.0M | 9.3M | 6.2M | 4.2M | 18.5M | 19.4M |
EMvision Medical Key Income Statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Income | 600.0 | 46.8K | 15.6K | 35.3K | 341.2K | 358.3K | |
| Interest Expense | 597.0 | 9.8K | 18.1K | 35.3K | 115.7K | 121.5K | |
| Total Revenue | 980.7K | 1.7M | 4.4M | 7.0M | 11.2M | 11.8M | |
| Gross Profit | 1.6M | 1.6M | 4.1M | 6.6M | 11.2M | 11.8M | |
| Operating Income | (3.5M) | (10.2M) | (10.5M) | (10.9M) | (1.6M) | (1.7M) | |
| Ebit | (3.5M) | (9.7M) | (8.1M) | (3.8M) | (2.5M) | (2.6M) | |
| Research Development | 2.9M | 2.7M | 2.3M | 2.0M | 4.7M | 2.8M | |
| Ebitda | (3.5M) | (9.6M) | (7.8M) | (3.5M) | (2.1M) | (2.2M) | |
| Income Before Tax | (3.5M) | (9.7M) | (8.1M) | (6.4M) | (2.0M) | (2.1M) | |
| Net Income | (5.1M) | (8.4M) | (6.1M) | (3.9M) | (2.7M) | (2.9M) | |
| Income Tax Expense | 1.6M | (1.3M) | (2.0M) | (2.5M) | 697.7K | 732.6K | |
| Net Interest Income | 36.4K | 37.0K | (2.5K) | 84.3K | 225.5K | 236.8K |
EMvision Medical Key Cash Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 1.0M | 4.3M | (2.9M) | 3.2M | 8.7M | 9.1M | |
| Free Cash Flow | (3.3M) | (4.6M) | (4.0M) | 646.9K | (6.3M) | (6.0M) | |
| Other Non Cash Items | 86.2K | 4.2M | 2.3M | 2.5M | 1.4M | 1.7M | |
| Net Income | (3.5M) | (8.4M) | (6.1M) | (3.9M) | (2.7M) | (2.9M) | |
| End Period Cash Flow | 5.4M | 9.7M | 6.8M | 10.0M | 18.6M | 19.5M | |
| Change To Netincome | 115.4K | 3.9M | 1.9M | 1.9M | 2.2M | 1.7M |
EMvision Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining EMvision Medical's current stock value. Our valuation model uses many indicators to compare EMvision Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across EMvision Medical competition to find correlations between indicators driving EMvision Medical's intrinsic value. More Info.EMvision Medical Devices is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the EMvision Medical's earnings, one of the primary drivers of an investment's value.EMvision Medical Devices Systematic Risk
EMvision Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. EMvision Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on EMvision Medical Devices correlated with the market. If Beta is less than 0 EMvision Medical generally moves in the opposite direction as compared to the market. If EMvision Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one EMvision Medical Devices is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of EMvision Medical is generally in the same direction as the market. If Beta > 1 EMvision Medical moves generally in the same direction as, but more than the movement of the benchmark.
EMvision Medical Devices Total Assets Over Time
EMvision Medical Thematic Clasifications
EMvision Medical Devices is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
EMvision Medical November 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of EMvision Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of EMvision Medical Devices. We use our internally-developed statistical techniques to arrive at the intrinsic value of EMvision Medical Devices based on widely used predictive technical indicators. In general, we focus on analyzing EMvision Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build EMvision Medical's daily price indicators and compare them against related drivers.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 15.88 | |||
| Value At Risk | (4.27) | |||
| Potential Upside | 5.94 |
Additional Tools for EMvision Stock Analysis
When running EMvision Medical's price analysis, check to measure EMvision Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EMvision Medical is operating at the current time. Most of EMvision Medical's value examination focuses on studying past and present price action to predict the probability of EMvision Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EMvision Medical's price. Additionally, you may evaluate how the addition of EMvision Medical to your portfolios can decrease your overall portfolio volatility.